Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Abitbol

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Gut|December 27, 2005
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trialP Marteau, M Lémann, P Seksik, et al.
Journal of Crohn'S & Colitis|February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort studyG Pineton de Chambrun, B Pariente, P Seksik, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2014
Olmesartan-associated enteropathy: results of a national surveyL Marthey, G Cadiot, P Seksik, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2024
Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide studyS Bendaoud, S Nahon, L Beaugerie, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohortS Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Journal of Crohn'S & Colitis|February 21, 2019
Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN StudyC Briot, P Faure, A L Parmentier, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Gut|December 27, 2005
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trialP Marteau, M Lémann, P Seksik, et al.
Journal of Crohn'S & Colitis|February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort studyG Pineton de Chambrun, B Pariente, P Seksik, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2014
Olmesartan-associated enteropathy: results of a national surveyL Marthey, G Cadiot, P Seksik, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2024
Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide studyS Bendaoud, S Nahon, L Beaugerie, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohortS Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Journal of Crohn'S & Colitis|February 21, 2019
Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN StudyC Briot, P Faure, A L Parmentier, et al.
Pageof 4